Literature DB >> 23778144

Nanoparticle clearance is governed by Th1/Th2 immunity and strain background.

Stephen W Jones1, Reid A Roberts, Gregory R Robbins, Jillian L Perry, Marc P Kai, Kai Chen, Tao Bo, Mary E Napier, Jenny P Y Ting, Joseph M Desimone, James E Bear.   

Abstract

Extended circulation of nanoparticles in blood is essential for most clinical applications. Nanoparticles are rapidly cleared by cells of the mononuclear phagocyte system (MPS). Approaches such as grafting polyethylene glycol onto particles (PEGylation) extend circulation times; however, these particles are still cleared, and the processes involved in this clearance remain poorly understood. Here, we present an intravital microscopy-based assay for the quantification of nanoparticle clearance, allowing us to determine the effect of mouse strain and immune system function on particle clearance. We demonstrate that mouse strains that are prone to Th1 immune responses clear nanoparticles at a slower rate than Th2-prone mice. Using depletion strategies, we show that both granulocytes and macrophages participate in the enhanced clearance observed in Th2-prone mice. Macrophages isolated from Th1 strains took up fewer particles in vitro than macrophages from Th2 strains. Treating macrophages from Th1 strains with cytokines to differentiate them into M2 macrophages increased the amount of particle uptake. Conversely, treating macrophages from Th2 strains with cytokines to differentiate them into M1 macrophages decreased their particle uptake. Moreover, these results were confirmed in human monocyte-derived macrophages, suggesting that global immune regulation has a significant impact on nanoparticle clearance in humans.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23778144      PMCID: PMC3696555          DOI: 10.1172/JCI66895

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Visualizing dynamics of sub-hepatic distribution of nanoparticles using intravital multiphoton fluorescence microscopy.

Authors:  Shih-Hsun Cheng; Feng-Chieh Li; Jeffrey S Souris; Chung-Shi Yang; Fan-Gang Tseng; Hsuan-Shu Lee; Chin-Tu Chen; Chen-Yuan Dong; Leu-Wei Lo
Journal:  ACS Nano       Date:  2012-04-19       Impact factor: 15.881

Review 2.  Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects.

Authors:  Jin-Wook Yoo; Elizabeth Chambers; Samir Mitragotri
Journal:  Curr Pharm Des       Date:  2010-07       Impact factor: 3.116

3.  Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles.

Authors:  Pinal C Patel; David A Giljohann; Weston L Daniel; Dan Zheng; Andrew E Prigodich; Chad A Mirkin
Journal:  Bioconjug Chem       Date:  2010-11-11       Impact factor: 4.774

4.  Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis.

Authors:  O Krysko; G Holtappels; N Zhang; M Kubica; K Deswarte; L Derycke; S Claeys; H Hammad; G G Brusselle; P Vandenabeele; D V Krysko; C Bachert
Journal:  Allergy       Date:  2010-10-25       Impact factor: 13.146

Review 5.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Authors:  Donald E Owens; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2005-11-21       Impact factor: 5.875

6.  Influence of polyethyleneglycol modification on phagocytic uptake of polymeric nanoparticles mediated by immunoglobulin G and complement activation.

Authors:  Anshu Yang; Wei Liu; Zhuoya Li; Linyu Jiang; Huibi Xu; Xiangliang Yang
Journal:  J Nanosci Nanotechnol       Date:  2010-01

7.  PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics.

Authors:  Jillian L Perry; Kevin G Reuter; Marc P Kai; Kevin P Herlihy; Stephen W Jones; J Chris Luft; Mary Napier; James E Bear; Joseph M DeSimone
Journal:  Nano Lett       Date:  2012-09-05       Impact factor: 11.189

8.  Intravenous administration of polyethylene glycol-coated (PEGylated) proteins and PEGylated adenovirus elicits an anti-PEG immunoglobulin M response.

Authors:  Taro Shimizu; Masako Ichihara; Yasuo Yoshioka; Tatsuhiro Ishida; Shinsaku Nakagawa; Hiroshi Kiwada
Journal:  Biol Pharm Bull       Date:  2012       Impact factor: 2.233

9.  Therapeutic siRNA silencing in inflammatory monocytes in mice.

Authors:  Florian Leuschner; Partha Dutta; Rostic Gorbatov; Tatiana I Novobrantseva; Jessica S Donahoe; Gabriel Courties; Kang Mi Lee; James I Kim; James F Markmann; Brett Marinelli; Peter Panizzi; Won Woo Lee; Yoshiko Iwamoto; Stuart Milstein; Hila Epstein-Barash; William Cantley; Jamie Wong; Virna Cortez-Retamozo; Andita Newton; Kevin Love; Peter Libby; Mikael J Pittet; Filip K Swirski; Victor Koteliansky; Robert Langer; Ralph Weissleder; Daniel G Anderson; Matthias Nahrendorf
Journal:  Nat Biotechnol       Date:  2011-10-09       Impact factor: 54.908

10.  Neutrophils and macrophages: the main partners of phagocyte cell systems.

Authors:  Manuel T Silva; Margarida Correia-Neves
Journal:  Front Immunol       Date:  2012-07-04       Impact factor: 7.561

View more
  75 in total

1.  Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle.

Authors:  Miles A Miller; Suresh Gadde; Christina Pfirschke; Camilla Engblom; Melissa M Sprachman; Rainer H Kohler; Katherine S Yang; Ashley M Laughney; Gregory Wojtkiewicz; Nazila Kamaly; Sushma Bhonagiri; Mikael J Pittet; Omid C Farokhzad; Ralph Weissleder
Journal:  Sci Transl Med       Date:  2015-11-18       Impact factor: 17.956

2.  Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using 64Cu-Labeled Macrin.

Authors:  Hye-Yeong Kim; Ran Li; Thomas S C Ng; Gabriel Courties; Christopher Blake Rodell; Mark Prytyskach; Rainer H Kohler; Mikael J Pittet; Matthias Nahrendorf; Ralph Weissleder; Miles A Miller
Journal:  ACS Nano       Date:  2018-12-11       Impact factor: 15.881

Review 3.  Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.

Authors:  Frederik Soetaert; Preethi Korangath; David Serantes; Steven Fiering; Robert Ivkov
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

4.  TIPS pentacene loaded PEO-PDLLA core-shell nanoparticles have similar cellular uptake dynamics in M1 and M2 macrophages and in corresponding in vivo microenvironments.

Authors:  Dylan K McDaniel; Ami Jo; Veronica M Ringel-Scaia; Sheryl Coutermarsh-Ott; Daniel E Rothschild; Michael D Powell; Rui Zhang; Timothy E Long; Kenneth J Oestreich; Judy S Riffle; Richey M Davis; Irving C Allen
Journal:  Nanomedicine       Date:  2016-12-29       Impact factor: 5.307

5.  Engineered PRINT(®) nanoparticles for controlled delivery of antigens and immunostimulants.

Authors:  Anton Beletskii; Ashley Galloway; Shyam Rele; Michele Stone; Frank Malinoski
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Surface area- and mass-based comparison of fine and ultrafine nickel oxide lung toxicity and augmentation of allergic response in an ovalbumin asthma model.

Authors:  Katherine A Roach; Stacey E Anderson; Aleksandr B Stefaniak; Hillary L Shane; Vamsi Kodali; Michael Kashon; Jenny R Roberts
Journal:  Inhal Toxicol       Date:  2019-11-11       Impact factor: 2.724

7.  PEGylation of model drug carriers enhances phagocytosis by primary human neutrophils.

Authors:  William J Kelley; Catherine A Fromen; Genesis Lopez-Cazares; Omolola Eniola-Adefeso
Journal:  Acta Biomater       Date:  2018-09-06       Impact factor: 8.947

8.  Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.

Authors:  Thomas J Anchordoquy; Yechezkel Barenholz; Diana Boraschi; Michael Chorny; Paolo Decuzzi; Marina A Dobrovolskaia; Z Shadi Farhangrazi; Dorothy Farrell; Alberto Gabizon; Hamidreza Ghandehari; Biana Godin; Ninh M La-Beck; Julia Ljubimova; S Moein Moghimi; Len Pagliaro; Ji-Ho Park; Dan Peer; Erkki Ruoslahti; Natalie J Serkova; Dmitri Simberg
Journal:  ACS Nano       Date:  2017-01-09       Impact factor: 15.881

Review 9.  Nanoparticle-Based Therapies for Wound Biofilm Infection: Opportunities and Challenges.

Authors:  Min-Ho Kim
Journal:  IEEE Trans Nanobioscience       Date:  2016-03-02       Impact factor: 2.935

10.  Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer.

Authors:  Charles J Bowerman; James D Byrne; Kevin S Chu; Allison N Schorzman; Amanda W Keeler; Candice A Sherwood; Jillian L Perry; James C Luft; David B Darr; Allison M Deal; Mary E Napier; William C Zamboni; Norman E Sharpless; Charles M Perou; Joseph M DeSimone
Journal:  Nano Lett       Date:  2016-12-22       Impact factor: 11.189

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.